Immunophenotypic characterization of canine lymphoproliferative disorders

Area of Science:

• Veterinary Oncology
• Immunology
• Canine Cancer Research

Background:

• Lymphoproliferative disorders are common in dogs.
• Accurate immunophenotyping is crucial for prognosis and understanding disease mechanisms.
• Canine lymphoma and leukemia share some similarities with human counterparts, but distinct differences exist.

Purpose of the Study:

• To immunophenotypically characterize canine lymphoproliferative disorders.
• To correlate specific cell lineages and antigen expression with clinical outcomes.
• To compare canine leukemia phenotypes with human leukemia.

Main Methods:

• Immunophenotyping of 196 dogs with spontaneously occurring lymphoproliferative disorders.
• Analysis of B-cell, T-cell, and null cell origins of lymphoma.
• Assessment of CD4+, CD8+, and B5 antigen expression.
• Correlation of immunophenotypic findings with relapse rates, survival times, and clinical signs like hypercalcemia.

Main Results:

• 76% of canine lymphomas were B-cell, 22% T-cell, and 2% null cell.
• T-cell lymphomas had significantly higher risks of relapse and early death compared to B-cell lymphomas.
• Hypercalcemia was associated with CD4+ lymphomas.
• Reduced B5 antigen expression in B-cell lymphoma correlated with shorter progression-free and overall survival.
• Canine chronic lymphocytic leukemia was mainly CD8+; acute lymphoblastic leukemia was null or T-cell.

Conclusions:

• Immunophenotyping provides critical prognostic information for canine lymphoma.
• T-cell lineage and reduced B5 antigen expression are negative prognostic indicators in canine lymphoma.
• Canine leukemia exhibits distinct phenotypes compared to human leukemia.
• Canine-specific probes aid in predicting treatment outcomes and understanding comparative leukemogenesis.